| Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer SA Tomlins, DR Rhodes, S Perner, SM Dhanasekaran, R Mehra, XW Sun, ... science 310 (5748), 644-648, 2005 | 4818 | 2005 |
| The polycomb group protein EZH2 is involved in progression of prostate cancer S Varambally, SM Dhanasekaran, M Zhou, TR Barrette, C Kumar-Sinha, ... Nature 419 (6907), 624-629, 2002 | 3273 | 2002 |
| The mutational landscape of lethal castration-resistant prostate cancer CS Grasso, YM Wu, DR Robinson, X Cao, SM Dhanasekaran, AP Khan, ... Nature 487 (7406), 239-243, 2012 | 2690 | 2012 |
| The landscape of long noncoding RNAs in the human transcriptome MK Iyer, YS Niknafs, R Malik, U Singhal, A Sahu, Y Hosono, TR Barrette, ... Nature genetics 47 (3), 199-208, 2015 | 2670 | 2015 |
| Delineation of prognostic biomarkers in prostate cancer SM Dhanasekaran, TR Barrette, D Ghosh, R Shah, S Varambally, ... Nature 412 (6849), 822-826, 2001 | 2154 | 2001 |
| The landscape of circular RNA in cancer JN Vo, M Cieslik, Y Zhang, S Shukla, L Xiao, Y Zhang, YM Wu, ... Cell 176 (4), 869-881. e13, 2019 | 1234 | 2019 |
| Transcriptome sequencing across a prostate cancer cohort identifies PCAT-1, an unannotated lincRNA implicated in disease progression JR Prensner, MK Iyer, OA Balbin, SM Dhanasekaran, Q Cao, JC Brenner, ... Nature biotechnology 29 (8), 742-749, 2011 | 1147 | 2011 |
| Integrative molecular concept modeling of prostate cancer progression SA Tomlins, R Mehra, DR Rhodes, X Cao, L Wang, SM Dhanasekaran, ... Nature genetics 39 (1), 41-51, 2007 | 1096 | 2007 |
| An integrated network of androgen receptor, polycomb, and TMPRSS2-ERG gene fusions in prostate cancer progression J Yu, J Yu, RS Mani, Q Cao, CJ Brenner, X Cao, X Wang, L Wu, J Li, M Hu, ... Cancer cell 17 (5), 443-454, 2010 | 1014 | 2010 |
| Distinct classes of chromosomal rearrangements create oncogenic ETS gene fusions in prostate cancer SA Tomlins, B Laxman, SM Dhanasekaran, BE Helgeson, X Cao, ... Nature 448 (7153), 595-599, 2007 | 1005 | 2007 |
| α-Methylacyl coenzyme A racemase as a tissue biomarker for prostate cancer MA Rubin, M Zhou, SM Dhanasekaran, S Varambally, TR Barrette, ... Jama 287 (13), 1662-1670, 2002 | 891 | 2002 |
| The long noncoding RNA SChLAP1 promotes aggressive prostate cancer and antagonizes the SWI/SNF complex JR Prensner, MK Iyer, A Sahu, IA Asangani, Q Cao, L Patel, IA Vergara, ... Nature genetics 45 (11), 1392-1398, 2013 | 717 | 2013 |
| Repression of E-cadherin by the polycomb group protein EZH2 in cancer Q Cao, J Yu, SM Dhanasekaran, JH Kim, RS Mani, SA Tomlins, R Mehra, ... Oncogene 27 (58), 7274-7284, 2008 | 658 | 2008 |
| New class of microRNA targets containing simultaneous 5′-UTR and 3′-UTR interaction sites I Lee, SS Ajay, JI Yook, HS Kim, SH Hong, NH Kim, SM Dhanasekaran, ... Genome research 19 (7), 1175-1183, 2009 | 622 | 2009 |
| Rearrangements of the RAF kinase pathway in prostate cancer, gastric cancer and melanoma N Palanisamy, B Ateeq, S Kalyana-Sundaram, D Pflueger, ... Nature medicine 16 (7), 793-798, 2010 | 550 | 2010 |
| Integrated proteogenomic characterization of clear cell renal cell carcinoma DJ Clark, SM Dhanasekaran, F Petralia, J Pan, X Song, Y Hu, ... Cell 179 (4), 964-983. e31, 2019 | 491 | 2019 |
| Proteogenomic characterization reveals therapeutic vulnerabilities in lung adenocarcinoma MA Gillette, S Satpathy, S Cao, SM Dhanasekaran, SV Vasaikar, K Krug, ... Cell 182 (1), 200-225. e35, 2020 | 463 | 2020 |
| Proteogenomic and metabolomic characterization of human glioblastoma LB Wang, A Karpova, MA Gritsenko, JE Kyle, S Cao, Y Li, D Rykunov, ... Cancer cell 39 (4), 509-528. e20, 2021 | 390 | 2021 |
| Proteogenomic characterization of endometrial carcinoma Y Dou, EA Kawaler, DC Zhou, MA Gritsenko, C Huang, L Blumenberg, ... Cell 180 (4), 729-748. e26, 2020 | 325 | 2020 |
| The distinctive mutational spectra of polyomavirus-negative Merkel cell carcinoma PW Harms, P Vats, ME Verhaegen, DR Robinson, YM Wu, ... Cancer research 75 (18), 3720-3727, 2015 | 324 | 2015 |
